
ASHLAND INC
ASHNYSETrading Snapshot
- Day Range
- $74.25 โ $75.68
- 52-Week Range
- $46.30 โ $78.25
- Volume
- $4.89B
- Avg Volume
- $4.08B
- Shares Outstanding
- 45.8M
- Next Earnings
- Oct 23, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.82B
- Last Q Revenue
- $497M
- P/E Ratio
- 67.8
- P/S Ratio
- 1.9x
- EPS (TTM)
- $1.16
- Dividend Yield
- 2.20%
Why Investors Own ASH
- โHigh-growth profile โ revenue up +16.7% YoY with expanding US Equity exposure.
- โHealthy economics โ 60% gross margin and 7% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ASHLAND INC
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

Ashland board authorizes quarterly dividend
WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock. The dividend will be payable on September 15, 2026, to stockholders of record at the close of business on September 1, 2026. As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients com
Ashland Is Said To Explore Sale After Getting Takeover Interest
- Bloomberg
Morgan Stanley Maintains Equal-Weight on Ashland, Raises Price Target to $78
Morgan Stanley maintains Ashland (NYSE:ASH) with a Equal-Weight and raises the price target from $58 to $78.

Ashland Inc. 2026 Q3 - Results - Earnings Call Presentation
2026-07-31. The following slide deck was published by Ashland Inc.
Wells Fargo Maintains Equal-Weight on Ashland, Raises Price Target to $70
Wells Fargo analyst Abigail Eberts maintains Ashland (NYSE:ASH) with a Equal-Weight and raises the price target from $50 to $70.
UBS Maintains Buy on Ashland, Raises Price Target to $83
UBS analyst Joshua Spector maintains Ashland (NYSE:ASH) with a Buy and raises the price target from $75 to $83.